Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring

NCT01515371 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Due to lack of sufficient eligible subjects, no safety concerns

Conditions

Habitual Snoring

Interventions

DRUG: IncobotulinumtoxinA
DRUG: Placebo Comparator

Sponsor

Merz Pharmaceuticals GmbH